BioTime and OncoCyte Corporation Publish Data on the Gene as a Marker and Potential Diagnostic for a Wide Array of Human Cancers BioTime, Inc.Peter Garcia, 510-521-3390 ext. 367Chief Financial ...
New Release Features “Super-Pathways” and Collaboration with Lost Island Labs, Inc. <0> BioTime, Inc.Peter Garcia, 510-521-3390, ext. 367Chief Financial OfficerJudith Segall, 510-521-3390, ext.
On August 2, 2018, BioTime Inc. (NYSE: BTX; $2.31; market capitalization: $293 million) announced results for 2Q18. BioTime primary clinical programs Renevia and OpRegen progressed on research and ...
Alameda-based BioTime, which has seen its stock double in the past year, reached an agreement this week to provide important embryonic stem cell lines to California-based researchers for free in hopes ...
In an effort to make stem cell treatments more viable in the field of regenerative medicine, BioTime ($BTX) has developed a delivery system designed to mimic the ...
MENLO PARK, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset ...
ALAMEDA, Calif. & MENLO PARK, Calif.--BioTime, Inc. (NYSE MKT: BTX) announced today that its subsidiary Asterias Biotherapeutics, Inc. ("Asterias"), has raised $12.5 million through the sale of ...
BioTime announced the results of its capital raising activities since October 1, 2013 through its $25M Controlled Equity Offering facility, and through sales of BioTime common shares by certain of its ...
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that on May 1, 2014, the Company received approximately ...
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has closed the previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results